For the last several years, a startup accelerator called Infinita City has devoted its attention to establishing a thriving enclave for biotech companies in Prospera, a charter city on a small Honduran island. Last year, Tim Draper, a billionaire venture capitalist who backed Infinita, hosted a pitch competition on the island that offered a $1 million investment prize. Longevity influencer Bryan Johnson has visited too, and he got dosed with an experimental gene therapy.

While Niklas Anzinger, Infinita’s founder and CEO, said he is proud of the company’s origin story, there hasn’t been enough demand from drug companies to test their medicines on the island. “It will take a very long time before it becomes a credible medical hub,” he said.

Instead, Infinita is turning its attention somewhere new: Montana.